These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 33633689)
1. The Recovery of Thyroid Function in Low-Risk Papillary Thyroid Cancer After Lobectomy: A 3-Year Follow-Up Study. Dou Y; Chen Y; Hu D; Su X Front Endocrinol (Lausanne); 2020; 11():619841. PubMed ID: 33633689 [TBL] [Abstract][Full Text] [Related]
2. Levothyroxine Cessation After Thyroid Lobectomy for Papillary Thyroid Cancer Can Be Achieved at the Same Rate as that for Benign Tumors Regardless of the Duration of Thyroid-stimulating Hormone Suppression. Na YM; Cho JS; Park MH Anticancer Res; 2021 Nov; 41(11):5713-5721. PubMed ID: 34732444 [TBL] [Abstract][Full Text] [Related]
3. Thyroid Hormone Supplementation Therapy for Differentiated Thyroid Cancer After Lobectomy: 5 Years of Follow-Up. Kim SY; Kim HJ; Kim SM; Chang H; Lee YS; Chang HS; Park CS Front Endocrinol (Lausanne); 2020; 11():520. PubMed ID: 32849303 [No Abstract] [Full Text] [Related]
4. Prediction of thyroid hormone supplementation after thyroid lobectomy. Lee DY; Seok J; Jeong WJ; Ahn SH J Surg Res; 2015 Jan; 193(1):273-8. PubMed ID: 25088372 [TBL] [Abstract][Full Text] [Related]
5. Factors associated with postoperative hypothyroidism after lobectomy in papillary thyroid microcarcinoma patients. Park HK; Kim DW; Ha TK; Choo HJ; Park YM; Jung SJ; Kim DH; Bae SK Endocr Res; 2015; 40(1):49-53. PubMed ID: 25111668 [TBL] [Abstract][Full Text] [Related]
6. Effects of endocrine therapy on the prognosis of elderly patients after surgery for papillary thyroid carcinoma. Xia Q; Dong S; Bian PD; Wang J; Li CJ Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1037-43. PubMed ID: 25744048 [TBL] [Abstract][Full Text] [Related]
7. Is thyroid hormone supplementation avoidable for patients with low-risk papillary thyroid cancer after thyroid lobectomy? A two-center observational study. Xiao L; Wu J; Jiang L; Xu Y; Liu B Clin Endocrinol (Oxf); 2022 Mar; 96(3):413-418. PubMed ID: 34398464 [TBL] [Abstract][Full Text] [Related]
8. Thyroid stimulating hormone suppression and recurrence after thyroid lobectomy for papillary thyroid carcinoma. Bae MR; Nam SH; Roh JL; Choi SH; Nam SY; Kim SY Endocrine; 2022 Feb; 75(2):487-494. PubMed ID: 34689317 [TBL] [Abstract][Full Text] [Related]
9. Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma. Lee SJ; Song CM; Ji YB; Choi YY; Sohn YS; Park JH; Kim DS; Tae K Langenbecks Arch Surg; 2021 Jun; 406(4):1223-1231. PubMed ID: 33970335 [TBL] [Abstract][Full Text] [Related]
10. Postoperative Thyroid-Stimulating Hormone Levels Did Not Affect Recurrence after Thyroid Lobectomy in Patients with Papillary Thyroid Cancer. Lee MC; Kim MJ; Choi HS; Cho SW; Lee GH; Park YJ; Park DJ Endocrinol Metab (Seoul); 2019 Jun; 34(2):150-157. PubMed ID: 31099202 [TBL] [Abstract][Full Text] [Related]
11. Oncological impact of hypothyroidism and levothyroxine supplementation following hemithyroidectomy in patients with papillary thyroid carcinoma. Ahn D; Lee GJ; Sohn JH; Jeon JH Head Neck; 2020 May; 42(5):1004-1013. PubMed ID: 31930773 [TBL] [Abstract][Full Text] [Related]
13. Clinical Features of Early and Late Postoperative Hypothyroidism After Lobectomy. Park S; Jeon MJ; Song E; Oh HS; Kim M; Kwon H; Kim TY; Hong SJ; Shong YK; Kim WB; Sung TY; Kim WG J Clin Endocrinol Metab; 2017 Apr; 102(4):1317-1324. PubMed ID: 28324106 [TBL] [Abstract][Full Text] [Related]
14. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224 [TBL] [Abstract][Full Text] [Related]
15. Postoperative thyroid hormone supplementation rates following thyroid lobectomy. Wilson M; Patel A; Goldner W; Baker J; Sayed Z; Fingeret AL Am J Surg; 2020 Nov; 220(5):1169-1173. PubMed ID: 32684294 [TBL] [Abstract][Full Text] [Related]
16. Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics. Baran JA; Bauer AJ; Halada S; Mostoufi-Moab S; Isaza A; Robbins S; Franco AT; Adzick NS; Patel T; Kazahaya K Thyroid; 2021 Dec; 31(12):1786-1793. PubMed ID: 34714171 [No Abstract] [Full Text] [Related]
17. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer. Park S; Jeon MJ; Oh HS; Lee YM; Sung TY; Han M; Han JM; Kim TY; Chung KW; Kim WB; Shong YK; Kim WG Thyroid; 2018 Aug; 28(8):997-1003. PubMed ID: 29845894 [TBL] [Abstract][Full Text] [Related]
18. Preoperative subclinical hypothyroidism in patients with papillary thyroid carcinoma. Ahn D; Sohn JH; Kim JH; Shin CM; Jeon JH; Park JY Am J Otolaryngol; 2013; 34(4):312-9. PubMed ID: 23357595 [TBL] [Abstract][Full Text] [Related]
19. Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy. Ito M; Miyauchi A; Hisakado M; Yoshioka W; Ide A; Kudo T; Nishihara E; Kihara M; Ito Y; Kobayashi K; Miya A; Fukata S; Nishikawa M; Nakamura H; Amino N Thyroid; 2017 Apr; 27(4):484-490. PubMed ID: 28056660 [TBL] [Abstract][Full Text] [Related]
20. Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients. Cho JW; Lee YM; Lee YH; Hong SJ; Yoon JH Clin Endocrinol (Oxf); 2018 Jul; 89(1):100-109. PubMed ID: 29672893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]